Prioritization of delayed vaccination for pandemic influenza

Limited production capacity and delays in vaccine development are major obstacles to vaccination programs that are designed to mitigate a pandemic influenza. In order to evaluate and compare the impact of various vaccination strategies during a pandemic influenza, we developed an age/risk-structured...

Full description

Saved in:
Bibliographic Details
Published inMathematical biosciences and engineering : MBE Vol. 8; no. 1; pp. 95 - 112
Main Author Shim, Eunha
Format Journal Article
LanguageEnglish
Published United States AIMS Press 01.01.2011
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Limited production capacity and delays in vaccine development are major obstacles to vaccination programs that are designed to mitigate a pandemic influenza. In order to evaluate and compare the impact of various vaccination strategies during a pandemic influenza, we developed an age/risk-structured model of influenza transmission, and parameterized it with epidemiological data from the 2009 H1N1 influenza A pandemic. Our model predicts that the impact of vaccination would be considerably diminished by delays in vaccination and staggered vaccine supply. Nonetheless, prioritizing limited H1N1 vaccine to individuals with a high risk of complications, followed by school-age children, and then preschool-age children, would minimize an overall attack rate as well as hospitalizations and deaths. This vaccination scheme would maximize the benefits of vaccination by protecting the high-risk people directly, and generating indirect protection by vaccinating children who are most likely to transmit the disease.
AbstractList Limited production capacity and delays in vaccine development are major obstacles to vaccination programs that are designed to mitigate a pandemic influenza. In order to evaluate and compare the impact of various vaccination strategies during a pandemic influenza, we developed an age/risk-structured model of influenza transmission, and parameterized it with epidemiological data from the 2009 H1N1 influenza A pandemic. Our model predicts that the impact of vaccination would be considerably diminished by delays in vaccination and staggered vaccine supply. Nonetheless, prioritizing limited H1N1 vaccine to individuals with a high risk of complications, followed by school-age children, and then preschool-age children, would minimize an overall attack rate as well as hospitalizations and deaths. This vaccination scheme would maximize the benefits of vaccination by protecting the high-risk people directly, and generating indirect protection by vaccinating children who are most likely to transmit the disease.
Limited production capacity and delays in vaccine development aremajor obstacles to vaccination programs that are designed tomitigate a pandemic influenza. In order to evaluate and compare theimpact of various vaccination strategies during a pandemic influenza, we developed an age/risk-structured model of influenzatransmission, and parameterized it with epidemiological data fromthe 2009 H1N1 influenza A pandemic. Our model predicts that theimpact of vaccination would be considerably diminished by delays invaccination and staggered vaccine supply. Nonetheless, prioritizing limited H1N1 vaccine toindividuals with a high risk of complications, followed byschool-age children, and then preschool-age children, would minimizean overall attack rate as well as hospitalizations anddeaths. This vaccination scheme would maximize the benefits ofvaccination by protecting the high-risk people directly, andgenerating indirect protection by vaccinating children who are mostlikely to transmit the disease.
Author Shim, Eunha
Author_xml – sequence: 1
  givenname: Eunha
  surname: Shim
  fullname: Shim, Eunha
  email: eshim@pitt.edu
  organization: Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA 15261, USA. eshim@pitt.edu
BackLink https://www.ncbi.nlm.nih.gov/pubmed/21361402$$D View this record in MEDLINE/PubMed
BookMark eNo90EtLw0AUBeBBFPvQpVvJH0icO3cmmQE3UnwUCrrQdbiZh0xJMiVNhfbXW6y6Ooez-BZnxs771HvGboAXaFDedY0vBAcodGHUGZuCUpBzDnrCZtvtmnOUiPKSTQRgCZKLKbt_G2Ia4hgPNMbUZylkzre09y77Imtjf5pDGrIN9c530WaxD-3O9we6YheB2q2__s05-3h6fF-85KvX5-XiYZVbqcSYY9CVqkTjOTlpnQTFndPGEwTjLZIowQhU2iruA0IA4pWxKCV4NFoqnLPlyXWJ1vVmiB0N-zpRrH-GNHzWNIzRtr4GS1QqxUFKIx2vGtJYuoBehKo6tqN1e7I2u6bz7l_7uwS_AcDhYd0
CitedBy_id crossref_primary_10_1007_s11538_022_01114_3
crossref_primary_10_1002_rmv_2475
crossref_primary_10_1007_s43069_023_00194_8
crossref_primary_10_3390_jcm10040591
crossref_primary_10_1016_j_epidem_2012_03_001
crossref_primary_10_1016_j_vaccine_2017_02_059
crossref_primary_10_17341_gazimmfd_758346
crossref_primary_10_46606_eajess2022v03i02_0165
crossref_primary_10_1515_cmb_2022_0147
crossref_primary_10_31202_ecjse_909927
ContentType Journal Article
DBID CGR
CUY
CVF
ECM
EIF
NPM
DOA
DOI 10.3934/mbe.2011.8.95
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
DOAJ Directory of Open Access Journals
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
DatabaseTitleList MEDLINE

Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ : directory of open access journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
EISSN 1551-0018
EndPage 112
ExternalDocumentID oai_doaj_org_article_1caa655014494d07ba836df3e2f7736d
21361402
Genre Journal Article
Comparative Study
Research Support, N.I.H., Extramural
GrantInformation_xml – fundername: NIGMS NIH HHS
  grantid: 5U54GM088491-02
– fundername: NIGMS NIH HHS
  grantid: U54 GM088491
GroupedDBID ---
53G
5GY
AENEX
ALMA_UNASSIGNED_HOLDINGS
CGR
CUY
CVF
EBD
EBS
ECM
EIF
EJD
EMOBN
F5P
GROUPED_DOAJ
IAO
ITC
J9A
ML0
NPM
OK1
P2P
RAN
SV3
TUS
ID FETCH-LOGICAL-c452t-3f87572be0ad4cd4150dd89ea1f9ec3a26192358c50ef31f1a079c3441e398453
IEDL.DBID DOA
IngestDate Wed Aug 27 01:26:52 EDT 2025
Thu Jan 02 22:59:09 EST 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c452t-3f87572be0ad4cd4150dd89ea1f9ec3a26192358c50ef31f1a079c3441e398453
OpenAccessLink https://doaj.org/article/1caa655014494d07ba836df3e2f7736d
PMID 21361402
PageCount 18
ParticipantIDs doaj_primary_oai_doaj_org_article_1caa655014494d07ba836df3e2f7736d
pubmed_primary_21361402
PublicationCentury 2000
PublicationDate 2011-01-01
PublicationDateYYYYMMDD 2011-01-01
PublicationDate_xml – month: 01
  year: 2011
  text: 2011-01-01
  day: 01
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Mathematical biosciences and engineering : MBE
PublicationTitleAlternate Math Biosci Eng
PublicationYear 2011
Publisher AIMS Press
Publisher_xml – name: AIMS Press
SSID ssj0034334
Score 1.8940535
Snippet Limited production capacity and delays in vaccine development are major obstacles to vaccination programs that are designed to mitigate a pandemic influenza....
Limited production capacity and delays in vaccine development aremajor obstacles to vaccination programs that are designed tomitigate a pandemic influenza. In...
SourceID doaj
pubmed
SourceType Open Website
Index Database
StartPage 95
SubjectTerms Adolescent
Adult
Age Factors
Aged
Child
Child, Preschool
delay
h1n1
Health Priorities
Humans
influenza
Influenza A Virus, H1N1 Subtype - immunology
Influenza Vaccines - administration & dosage
Influenza Vaccines - immunology
Influenza, Human - immunology
Influenza, Human - prevention & control
Influenza, Human - transmission
Influenza, Human - virology
Middle Aged
Models, Immunological
Models, Statistical
optimal
pandemic
Pandemics - prevention & control
vaccination
Young Adult
Title Prioritization of delayed vaccination for pandemic influenza
URI https://www.ncbi.nlm.nih.gov/pubmed/21361402
https://doaj.org/article/1caa655014494d07ba836df3e2f7736d
Volume 8
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3PS8MwFA4yELyIv52_yMFrXdqXtil4UXEMYWMHB7uV5CWBHvaDMYX51_vSTBEvXoRSSlte2q8035fX5nuM3ZbeqkoBJl7T6yZR-ETTqQlIgybLlNE-zB0ejorBRL5M8-mPUl_hn7BoDxyB66WodZGHr1-yklaURisorAeX-bKkrdD7Eud9DaZiHwwSQEZHTahA9mbGRbdOdRcKSbTu_L90ZMsn_QO2vxWC_CFewCHbcfMjthtLQ26O2f141SyC4VCcJskXngc_x42z_F0jNjGJx0ly8mXIA88a5E0sOPKhT9ik__z6NEi2lQ4SlHm2TsAHX_nMOKGtREukKixh6HTqK4eg4zAnV5gL5yH1qRZlhUBSxkGlZA6nrDNfzN0546jQiFxpUJKOk_7DUhiKqKkhXxrXZY_h7utlNLOog710u4NAr7eg13-B3mVnEbvvMFkKRPQiu_iP8JdsL6Zuw3LFOuvVm7sm7l-bm_Yx03o0Hn4CdTWtng
linkProvider Directory of Open Access Journals
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Prioritization+of+delayed+vaccination+for+pandemic+influenza&rft.jtitle=Mathematical+biosciences+and+engineering+%3A+MBE&rft.au=Eunha+Shim&rft.date=2011-01-01&rft.pub=AIMS+Press&rft.eissn=1551-0018&rft.volume=8&rft.issue=1&rft.spage=95&rft.epage=112&rft_id=info:doi/10.3934%2Fmbe.2011.8.95&rft.externalDBID=DOA&rft.externalDocID=oai_doaj_org_article_1caa655014494d07ba836df3e2f7736d